Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82,890 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ruxolitinib combined with etanercept induce a rapid response to corticosteroid-refractory severe acute graft vs host disease after allogeneic stem cell transplantation: Results of a multi-center prospective study.
Zhao Y, Wu H, Shi J, Luo Y, Li X, Lan J, Ni W, Lu Y, Chen L, Tan Y, Lai X, Yu J, Huang H. Zhao Y, et al. Among authors: chen l. Am J Hematol. 2020 Sep;95(9):1075-1084. doi: 10.1002/ajh.25898. Epub 2020 Jul 6. Am J Hematol. 2020. PMID: 32510625 Free article. Clinical Trial.
Venetoclax plus hypomethylating agent for the salvage treatment of relapsing myeloid malignancies after hematopoietic stem cell transplantation: A multicenter retrospective study on behalf of the Zhejiang Cooperative Group for Blood and Marrow Transplantation.
Gao F, Gao Y, Luo Y, Yu J, Fu H, Lai X, Liu L, Ye B, Lan J, Song X, Lu Y, Chen L, Chen Y, Yu K, Huang H, Shi J, Zhao Y. Gao F, et al. Among authors: chen l, chen y. Am J Hematol. 2022 Feb 1;97(2):E44-E47. doi: 10.1002/ajh.26405. Epub 2021 Nov 24. Am J Hematol. 2022. PMID: 34778993 Free article. No abstract available.
Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia and myelodysplastic syndrome.
Cao J, Pei R, Lu Y, Zheng Z, Yuan Z, Li D, Zhang P, Liu X, Chen D, Du X, Chen L, Li S, Ye P, Wang T. Cao J, et al. Among authors: chen l, chen d. Curr Res Transl Med. 2023 Jan-Mar;71(1):103360. doi: 10.1016/j.retram.2022.103360. Epub 2022 Aug 2. Curr Res Transl Med. 2023. PMID: 36427418
[Clinical Value of Translocator Protein Gene in Evaluating the Efficacy of FLT3-ITD/DNMT3A R882 Double-Mutated Acute Myeloid Leukemia].
Tang SH, Lu Y, Zhang PS, Chen D, Liu XH, DU XH, Cao JJ, Li SY, Sha KY, Chen LG, Zhuang XX, Ye PP, Lin L, Pei RZ. Tang SH, et al. Among authors: chen d, chen lg. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023 Feb;31(1):45-49. doi: 10.19746/j.cnki.issn.1009-2137.2023.01.007. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2023. PMID: 36765475 Chinese.
[Clinical investigation of homoharringtonine in combination with all-transretinoic acid and arsenic trioxide for acute promyelocytic leukemia].
Pei RZ, Li SY, Zhang PS, Ma JX, Liu XH, Du XH, Chen D, Sha KY, Chen LG, Cao JJ, Zhuang XX, Wu JY, Lin L, Fan Z, Ye PP, Tang SH, Zhang BB, Shi XW. Pei RZ, et al. Among authors: chen d, chen lg. Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):144-8. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23611222 Clinical Trial. Chinese.
82,890 results
You have reached the last available page of results. Please see the User Guide for more information.